AU6071301A - Medical composition kit for treating lesioned abnormal tissue - Google Patents

Medical composition kit for treating lesioned abnormal tissue

Info

Publication number
AU6071301A
AU6071301A AU6071301A AU6071301A AU6071301A AU 6071301 A AU6071301 A AU 6071301A AU 6071301 A AU6071301 A AU 6071301A AU 6071301 A AU6071301 A AU 6071301A AU 6071301 A AU6071301 A AU 6071301A
Authority
AU
Australia
Prior art keywords
similar
composition kit
medical composition
abnormal tissue
preparation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
AU6071301A
Other languages
English (en)
Inventor
Kinuko Oku
Takako Iwamoto
Takashi Ono
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Mitsubishi Pharma Corp
Lequio Pharma Co Ltd
Original Assignee
Mitsubishi Pharma Corp
Lequio Pharma Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mitsubishi Pharma Corp, Lequio Pharma Co Ltd filed Critical Mitsubishi Pharma Corp
Publication of AU6071301A publication Critical patent/AU6071301A/xx
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/235—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
    • A61K31/24—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group having an amino or nitro group
    • A61K31/245—Amino benzoic acid types, e.g. procaine, novocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0031—Rectum, anus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A61P23/02—Local anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Inorganic Chemistry (AREA)
  • Emergency Medicine (AREA)
  • Anesthesiology (AREA)
  • Pain & Pain Management (AREA)
  • Vascular Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Materials For Medical Uses (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU6071301A 2000-06-06 2001-06-05 Medical composition kit for treating lesioned abnormal tissue Pending AU6071301A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2000168502 2000-06-06
PCT/JP2001/004720 WO2001093856A1 (fr) 2000-06-06 2001-06-05 Kit de composition medicale destine a traiter un tissu anormal lese

Publications (1)

Publication Number Publication Date
AU6071301A true AU6071301A (en) 2001-12-17

Family

ID=18671494

Family Applications (2)

Application Number Title Priority Date Filing Date
AU6071301A Pending AU6071301A (en) 2000-06-06 2001-06-05 Medical composition kit for treating lesioned abnormal tissue
AU2001260713A Ceased AU2001260713B2 (en) 2000-06-06 2001-06-05 Medical composition kit for treating lesioned abnormal tissue

Family Applications After (1)

Application Number Title Priority Date Filing Date
AU2001260713A Ceased AU2001260713B2 (en) 2000-06-06 2001-06-05 Medical composition kit for treating lesioned abnormal tissue

Country Status (10)

Country Link
US (1) US7381419B2 (de)
EP (1) EP1300141B1 (de)
JP (1) JP4865183B2 (de)
KR (1) KR100722649B1 (de)
AT (1) ATE389393T1 (de)
AU (2) AU6071301A (de)
CA (1) CA2408887C (de)
DE (1) DE60133284T2 (de)
ES (1) ES2303832T3 (de)
WO (1) WO2001093856A1 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004052354A1 (ja) * 2002-12-06 2004-06-24 Otsuka Pharmaceutical Factory, Inc. プロポフォール含有脂肪乳剤
US7658288B2 (en) * 2004-11-08 2010-02-09 Applied Biosystems, Llc Bisulfite conversion reagent
EP3895737A1 (de) 2007-06-29 2021-10-20 Stelic Institute Of Regenerative Medicine, Stelic Institute & Co. Verfahren zur fixierung und expression einer physiologisch aktiven substanz
DE102008037682A1 (de) 2008-08-14 2010-04-08 Strackharn, Klaus, Dr.med. Verwendung äquipotenter Dosierungen von Lokalanästetika oder Derivaten davon zur Therapie chronischer Schmerzen
CN113893264A (zh) * 2021-11-22 2022-01-07 中国人民解放军总医院 治疗肿瘤的方法和组合物

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2312715A (en) * 1939-10-04 1943-03-02 Stanco Inc Emulsion for burn treatment
US2696456A (en) * 1950-04-24 1954-12-07 Lambert Company Dual element suppository
US2824042A (en) * 1954-06-18 1958-02-18 Walter G Gibbons Composition for preparation of burow's solution
US4307075A (en) * 1979-09-13 1981-12-22 American Home Products Corporation Topical treatment of aphthous stomatitis
US4265883A (en) * 1979-10-01 1981-05-05 Cameron Mable R Composition and process for treating uterine prolapse
JPS56139423A (en) * 1980-04-02 1981-10-30 Toyo Seiyaku Kasei Kk Hemostatic agent for dental oral use
US4963591A (en) * 1985-12-16 1990-10-16 Carter-Wallace Inc. Cosmetic compositions
US4797392A (en) * 1987-01-27 1989-01-10 Chernomorsky Simon A Use of anorectal compositions
SE9202128D0 (sv) * 1992-07-09 1992-07-09 Astra Ab Precipitation of one or more active compounds in situ
US5750150A (en) * 1992-09-18 1998-05-12 Traditional Chinese Medicine Research Laboratory, Inc. Compositions for treating affected tissues, method for the preparation and usage thereof
EP0617964B1 (de) * 1992-09-18 2002-08-21 Lequio Pharma Co., Ltd. Injektion zur heilung von verletztem abnormem gewebe, verfahren zu ihrer herstellung und ihre verwendung
JP3714972B2 (ja) 1992-09-18 2005-11-09 レキオファーマ株式会社 病変組織異常血管の注射用止血剤
CN1029729C (zh) * 1993-05-18 1995-09-13 苏宁芳 治疗内痔的注射液
JP3775813B2 (ja) * 1993-11-17 2006-05-17 レキオファーマ株式会社 病変異常組織治療用組成物，その製造方法およびその用途
KR100329256B1 (ko) * 1993-11-17 2002-11-04 미츠비시 파마 코포레이션 병변이상조직 치료용 조성물,그의 제조방법 및 용도
CN1114193A (zh) * 1994-06-28 1996-01-03 张建军 一种高效硬化剂及制备方法
AU707079B2 (en) * 1995-09-07 1999-07-01 Taisho Pharmaceutical Co., Ltd. Long active composition for rectal administration
JPH09143079A (ja) * 1995-11-21 1997-06-03 Chiyuuyakuken:Kk 病変異常組織治療用外用剤
JPH09227383A (ja) * 1996-02-23 1997-09-02 Chiyuuyakuken:Kk 直腸病変組織治療用座薬
IN186803B (de) * 1997-02-05 2001-11-10 Panacea Biotec Ltd
US5971953A (en) * 1998-01-09 1999-10-26 Bachynsky; Nicholas Dual chamber syringe apparatus
ID21009A (id) * 1997-10-08 1999-04-08 Taisho Pharmaceutical Co Ltd Komposisi untuk supositori
US6479058B1 (en) * 1999-09-02 2002-11-12 Mccadden Michael E. Composition for the topical treatment of poison ivy and other forms of contact dermatitis
US6432415B1 (en) * 1999-12-17 2002-08-13 Axrix Laboratories, Inc. Pharmaceutical gel and aerosol formulations and methods to administer the same to skin and mucosal surfaces

Also Published As

Publication number Publication date
CA2408887C (en) 2008-08-12
CA2408887A1 (en) 2002-11-13
ATE389393T1 (de) 2008-04-15
EP1300141B1 (de) 2008-03-19
AU2001260713B2 (en) 2005-08-11
ES2303832T3 (es) 2008-09-01
EP1300141A4 (de) 2003-07-16
US7381419B2 (en) 2008-06-03
WO2001093856A1 (fr) 2001-12-13
US20030191070A1 (en) 2003-10-09
JP4865183B2 (ja) 2012-02-01
DE60133284T2 (de) 2009-03-26
EP1300141A1 (de) 2003-04-09
KR100722649B1 (ko) 2007-05-28
KR20030005436A (ko) 2003-01-17
DE60133284D1 (de) 2008-04-30

Similar Documents

Publication Publication Date Title
PL317105A1 (en) Compositions containing dna and p53 damaging agents
GB2388786A (en) Dental floss with usage identification capability
IL195723A (en) Use of p53 inhibitors for the preparation of medicament
GEP20022784B (en) Celecoxib Composition
MXPA02011303A (es) Nueva composicion farmaceutica.
DE69621012D1 (de) VERWENDUNG VON NSAIDs ZUR BEHANDLUNG VON PLATTENEPITHELKARZINOM DER MUNDHÖHLE UND KEHLKOPF
GEP20043314B (en) Pharmaceutical Composition Comprising Entacapone, Levodopa, and Carbidopa
TW200602350A (en) Methods and compositions for treating hepatitis C virus
CA2388939A1 (en) Therapeutic treatments for blood cell deficiencies
MY111260A (en) Pharmaceutical composition for the treatment of nicotine dependence
MY164077A (en) Compositions and uses of et743 for treating cancer
AU6178198A (en) Method of treating a tumor
WO2001041754A3 (en) Inhibitors of collagen-induced platelet aggregation
AU6071301A (en) Medical composition kit for treating lesioned abnormal tissue
IL126235A (en) Compounds with growth hormone releasing properties, pharmaceutical compositions comprising them and their use
WO1999061010A3 (en) Treatment of infertility with cam-increasing compounds alone or in combination with at least one meiosis-stimulating compound
GR3032041T3 (en) Idebenone compositions for treating Alzheimer's disease.
BR0201974A (pt) Composição farmacêutica para tratamento de alterações do sono
HUP0401042A2 (hu) Primer álmatlanság kezelésére alkalmas gyógyszerkészítmények
AP1896A (en) The method of treating cancer
RU2003127718A (ru) Применение флумазенила в производстве лекарственного средства для лечения кокаиновой зависимости
GR1003490B (el) Νεες φαρμακευτικες συνθεσεις που περιεχουν αλας παροξετινης
YU46302A (sh) Supstituisani piroli
UA27230C2 (uk) Похідні андростану, заміщені по 16-му положенню четвертинною амонієвою групою, для використання як нервово-м'язових блокаторів та фармацевтична композиція, що здатна викликати нервово-м'язову блокаду
IL129267A (en) Pharmaceutical compositions comprising histamine and/or serotonin for treatment of urinary incontinence